Logo image of MAC

MACERICH CO/THE (MAC) Stock Fundamental Analysis

NYSE:MAC - New York Stock Exchange, Inc. - US5543821012 - REIT - Currency: USD

15.62  -0.45 (-2.8%)

After market: 15.62 0 (0%)

Fundamental Rating

2

Overall MAC gets a fundamental rating of 2 out of 10. We evaluated MAC against 129 industry peers in the Diversified REITs industry. MAC has a bad profitability rating. Also its financial health evaluation is rather negative. MAC is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year MAC was profitable.
In the past year MAC had a positive cash flow from operations.
In the past 5 years MAC reported 4 times negative net income.
In the past 5 years MAC always reported a positive cash flow from operatings.
MAC Yearly Net Income VS EBIT VS OCF VS FCFMAC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

1.2 Ratios

MAC's Return On Assets of -3.76% is on the low side compared to the rest of the industry. MAC is outperformed by 81.40% of its industry peers.
MAC has a Return On Equity of -11.67%. This is in the lower half of the industry: MAC underperforms 75.97% of its industry peers.
MAC has a Return On Invested Capital of 1.89%. This is in the lower half of the industry: MAC underperforms 68.99% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for MAC is in line with the industry average of 3.16%.
The 3 year average ROIC (1.71%) for MAC is below the current ROIC(1.89%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -3.76%
ROE -11.67%
ROIC 1.89%
ROA(3y)-2.25%
ROA(5y)-1.82%
ROE(3y)-6.88%
ROE(5y)-6.09%
ROIC(3y)1.71%
ROIC(5y)1.43%
MAC Yearly ROA, ROE, ROICMAC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

The Operating Margin of MAC (17.20%) is worse than 60.47% of its industry peers.
In the last couple of years the Operating Margin of MAC has declined.
MAC has a Gross Margin of 52.60%. This is in the lower half of the industry: MAC underperforms 75.97% of its industry peers.
MAC's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 17.2%
PM (TTM) N/A
GM 52.6%
OM growth 3Y6.69%
OM growth 5Y-4.17%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.18%
GM growth 5Y-2.5%
MAC Yearly Profit, Operating, Gross MarginsMAC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

0

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), MAC is destroying value.
Compared to 1 year ago, MAC has more shares outstanding
MAC has more shares outstanding than it did 5 years ago.
The debt/assets ratio for MAC is higher compared to a year ago.
MAC Yearly Shares OutstandingMAC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
MAC Yearly Total Debt VS Total AssetsMAC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

Based on the Altman-Z score of 0.04, we must say that MAC is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.04, MAC is doing worse than 75.97% of the companies in the same industry.
The Debt to FCF ratio of MAC is 92.05, which is on the high side as it means it would take MAC, 92.05 years of fcf income to pay off all of its debts.
MAC's Debt to FCF ratio of 92.05 is in line compared to the rest of the industry. MAC outperforms 56.59% of its industry peers.
MAC has a Debt/Equity ratio of 1.81. This is a high value indicating a heavy dependency on external financing.
MAC's Debt to Equity ratio of 1.81 is on the low side compared to the rest of the industry. MAC is outperformed by 68.22% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.81
Debt/FCF 92.05
Altman-Z 0.04
ROIC/WACC0.28
WACC6.63%
MAC Yearly LT Debt VS Equity VS FCFMAC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.3 Liquidity

MAC has a Current Ratio of 0.54. This is a bad value and indicates that MAC is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.54, MAC is doing worse than 75.97% of the companies in the same industry.
MAC has a Quick Ratio of 0.54. This is a bad value and indicates that MAC is not financially healthy enough and could expect problems in meeting its short term obligations.
MAC's Quick ratio of 0.54 is on the low side compared to the rest of the industry. MAC is outperformed by 75.19% of its industry peers.
Industry RankSector Rank
Current Ratio 0.54
Quick Ratio 0.54
MAC Yearly Current Assets VS Current LiabilitesMAC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

4

3. Growth

3.1 Past

MAC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 106.13%, which is quite impressive.
The Revenue has been growing slightly by 3.86% in the past year.
Measured over the past years, MAC shows a decrease in Revenue. The Revenue has been decreasing by -0.20% on average per year.
EPS 1Y (TTM)106.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%155.93%
Revenue 1Y (TTM)3.86%
Revenue growth 3Y2.71%
Revenue growth 5Y-0.2%
Sales Q2Q%19.37%

3.2 Future

Based on estimates for the next years, MAC will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.57% on average per year.
Based on estimates for the next years, MAC will show a small growth in Revenue. The Revenue will grow by 5.92% on average per year.
EPS Next Y88.39%
EPS Next 2Y42.1%
EPS Next 3Y28.36%
EPS Next 5Y17.57%
Revenue Next Year10.32%
Revenue Next 2Y4.85%
Revenue Next 3Y2.8%
Revenue Next 5Y5.92%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
MAC Yearly Revenue VS EstimatesMAC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 200M 400M 600M 800M 1B
MAC Yearly EPS VS EstimatesMAC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 -1 2 3

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 156.20, MAC can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of MAC indicates a slightly more expensive valuation: MAC is more expensive than 70.54% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of MAC to the average of the S&P500 Index (24.85), we can say MAC is valued expensively.
The Price/Forward Earnings ratio is 984.43, which means the current valuation is very expensive for MAC.
MAC's Price/Forward Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 20.89, MAC is valued quite expensively.
Industry RankSector Rank
PE 156.2
Fwd PE 984.43
MAC Price Earnings VS Forward Price EarningsMAC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 200 400 600 800

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MAC is valued a bit more expensive than 79.07% of the companies in the same industry.
MAC's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 72.7
EV/EBITDA 17.94
MAC Per share dataMAC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
MAC's earnings are expected to grow with 28.36% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.77
PEG (5Y)N/A
EPS Next 2Y42.1%
EPS Next 3Y28.36%

4

5. Dividend

5.1 Amount

MAC has a Yearly Dividend Yield of 4.11%, which is a nice return.
The stock price of MAC dropped by -23.80% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
Compared to an average industry Dividend Yield of 6.64, MAC is paying slightly less dividend.
MAC's Dividend Yield is rather good when compared to the S&P500 average which is at 2.40.
Industry RankSector Rank
Dividend Yield 4.11%

5.2 History

The dividend of MAC decreases each year by -25.88%.
MAC has paid a dividend for at least 10 years, which is a reliable track record.
MAC has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-25.88%
Div Incr Years2
Div Non Decr Years3
MAC Yearly Dividends per shareMAC Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

The earnings of MAC are negative and hence is the payout ratio. MAC will probably not be able to sustain this dividend level.
DP-46.26%
EPS Next 2Y42.1%
EPS Next 3Y28.36%
MAC Yearly Income VS Free CF VS DividendMAC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M

MACERICH CO/THE

NYSE:MAC (5/14/2025, 8:04:00 PM)

After market: 15.62 0 (0%)

15.62

-0.45 (-2.8%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)05-12 2025-05-12/bmo
Earnings (Next)07-29 2025-07-29/bmo
Inst Owners98.91%
Inst Owner Change-0.61%
Ins Owners0.29%
Ins Owner Change0.26%
Market Cap3.95B
Analysts55.45
Price Target19.1 (22.28%)
Short Float %6.02%
Short Ratio6.01
Dividend
Industry RankSector Rank
Dividend Yield 4.11%
Yearly Dividend0.64
Dividend Growth(5Y)-25.88%
DP-46.26%
Div Incr Years2
Div Non Decr Years3
Ex-Date06-03 2025-06-03 (0.17)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-1377.61%
Min EPS beat(2)-1955.13%
Max EPS beat(2)-800.09%
EPS beat(4)1
Avg EPS beat(4)-303.9%
Min EPS beat(4)-1955.13%
Max EPS beat(4)2110%
EPS beat(8)3
Avg EPS beat(8)-443.6%
EPS beat(12)3
Avg EPS beat(12)-354.33%
EPS beat(16)5
Avg EPS beat(16)-239.82%
Revenue beat(2)2
Avg Revenue beat(2)12.89%
Min Revenue beat(2)3.11%
Max Revenue beat(2)22.66%
Revenue beat(4)3
Avg Revenue beat(4)7.32%
Min Revenue beat(4)-0.58%
Max Revenue beat(4)22.66%
Revenue beat(8)7
Avg Revenue beat(8)5.16%
Revenue beat(12)9
Avg Revenue beat(12)3.65%
Revenue beat(16)13
Avg Revenue beat(16)4.87%
PT rev (1m)-6.92%
PT rev (3m)-11.78%
EPS NQ rev (1m)0%
EPS NQ rev (3m)20%
EPS NY rev (1m)-57.15%
EPS NY rev (3m)29.28%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)9.93%
Revenue NY rev (1m)0.24%
Revenue NY rev (3m)7.21%
Valuation
Industry RankSector Rank
PE 156.2
Fwd PE 984.43
P/S 3.5
P/FCF 72.7
P/OCF 13.92
P/B 1.43
P/tB 1.56
EV/EBITDA 17.94
EPS(TTM)0.1
EY0.64%
EPS(NY)0.02
Fwd EY0.1%
FCF(TTM)0.21
FCFY1.38%
OCF(TTM)1.12
OCFY7.18%
SpS4.46
BVpS10.91
TBVpS10.01
PEG (NY)1.77
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.76%
ROE -11.67%
ROCE 2.39%
ROIC 1.89%
ROICexc 1.91%
ROICexgc 2%
OM 17.2%
PM (TTM) N/A
GM 52.6%
FCFM 4.82%
ROA(3y)-2.25%
ROA(5y)-1.82%
ROE(3y)-6.88%
ROE(5y)-6.09%
ROIC(3y)1.71%
ROIC(5y)1.43%
ROICexc(3y)1.73%
ROICexc(5y)1.46%
ROICexgc(3y)1.79%
ROICexgc(5y)1.51%
ROCE(3y)2.16%
ROCE(5y)1.81%
ROICexcg growth 3Y9.63%
ROICexcg growth 5Y-3.26%
ROICexc growth 3Y9.11%
ROICexc growth 5Y-3.53%
OM growth 3Y6.69%
OM growth 5Y-4.17%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.18%
GM growth 5Y-2.5%
F-Score3
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 1.81
Debt/FCF 92.05
Debt/EBITDA 10
Cap/Depr 74.92%
Cap/Sales 20.33%
Interest Coverage 1.04
Cash Conversion 56.72%
Profit Quality N/A
Current Ratio 0.54
Quick Ratio 0.54
Altman-Z 0.04
F-Score3
WACC6.63%
ROIC/WACC0.28
Cap/Depr(3y)47.12%
Cap/Depr(5y)31.57%
Cap/Sales(3y)15.89%
Cap/Sales(5y)10.84%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)106.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%155.93%
EPS Next Y88.39%
EPS Next 2Y42.1%
EPS Next 3Y28.36%
EPS Next 5Y17.57%
Revenue 1Y (TTM)3.86%
Revenue growth 3Y2.71%
Revenue growth 5Y-0.2%
Sales Q2Q%19.37%
Revenue Next Year10.32%
Revenue Next 2Y4.85%
Revenue Next 3Y2.8%
Revenue Next 5Y5.92%
EBIT growth 1Y9.11%
EBIT growth 3Y9.58%
EBIT growth 5Y-4.36%
EBIT Next Year239.17%
EBIT Next 3Y50.85%
EBIT Next 5YN/A
FCF growth 1Y-68.85%
FCF growth 3Y-40.36%
FCF growth 5Y-30.47%
OCF growth 1Y-4.08%
OCF growth 3Y-0.35%
OCF growth 5Y-4.41%